Tools

LEADER 03743nam 2200553 i 4500

001 on1375231967;

003 OCoLC;

005 20230725093047.0;

006 m o d f ;

007 cr |||||||||||;

008 230407s2023 dcua ob f000 0 eng c;

024 8 a| 46-775q| (GPO jacket number);

035 a| (Sirsi) o1375231967;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 1043-C (online);

086 0 a| Y 4.L 11/4:S.HRG.117-195;

245 14 a| The path forward :b| a federal perspective on the Covid-19 response : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session on examining a federal perspective on the Covid-19 response, focusing on the path forward, after receiving testimony from Rochelle P. Walensky, Director, Centers for Disease Control and Prevention, Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Janet Woodcock, Acting Commissioner of Food and Drugs, Food and Drug Administration, and Dawn O'Connell, Assistant Secretary for Preparedness and Response, all of the Department of Health and Human Services, July 20, 2021.;

264 1 a| Washington :b| U.S. Government Publishing Office,c| 2023.;

300 a| 1 online resource (iii, 96 pages) :b| color illustration.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| S. hrg. ;v| 117-195;

500 a| Access ID (govinfo): CHRG-117shrg46775.;

500 a| In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

511 0 a| Hearing witnesses: Walensky, Rochelle, M.D., MPH, Director, United States Centers for Disease Control and Prevention, Atlanta, GA; Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Woodcock, Janet, M.D., Acting Commissioner, United States Food and Drug Administration, Silver Spring, MD; O'Connell, Dawn, Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.;

518 a| Date of hearing: 2021-07-20.;

588 a| Description based on online resource; title from PDF title page (GovInfo, viewed April 07, 2023).;

650 0 a| COVID-19 (Disease)0| https://id.loc.gov/authorities/subjects/sh2020000570=| ^A1407776;

650 0 a| COVID-19 (Disease)z| United Statesx| Safety measures.=| ^A1407776;

650 0 a| Coronavirus infectionsx| Prevention.=| ^A828712;

650 7 a| Health.2| cgpa;

655 7 a| Legislative hearings.2| lcgft0| https://id.loc.gov/authorities/genreForms/gf2013025047;

776 08 i| Print version:a| United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.t| Path forwardw| (OCoLC)1375231973;

856 40 u| https://purl.fdlp.gov/GPO/gpo1950387| 0;

922 a| BIBCONEWb| 20230407;

922 a| GOVINFOHRG;

922 a| PUBPOLTERMS;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6142918;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6142918-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 5/24/2023x| EDOCUMENTz| JERESOURCE;

The path forward : a federal perspective on the Covid-19 response : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, first session on examining a federal perspective on the Covid-19 response, focusing on the path forward, after receiving testimony from Rochelle P. Walensky, Director, Centers for Disease Control and Prevention, Anthony S. Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Janet Woodcock, Acting Commissioner of Food and Drugs, Food and Drug Administration, and Dawn O'Connell, Assistant Secretary for Preparedness and Response, all of the Department of Health and Human Services, July 20, 2021.

Author/creator	United States
Format	Electronic
Publication	Washington : U.S. Government Publishing Office, 2023.
Description	1 online resource (iii, 96 pages) : color illustration.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo195038
Subjects	COVID-19 (Disease) COVID-19 (Disease)--United States. --Safety measures. Coronavirus infections--Prevention.

Series	S. hrg. ; 117-195 United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 117-195. ^A500722
General note	Access ID (govinfo): CHRG-117shrg46775.
General note	In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Performer	Hearing witnesses: Walensky, Rochelle, M.D., MPH, Director, United States Centers for Disease Control and Prevention, Atlanta, GA; Fauci, Anthony, M.D., Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; Woodcock, Janet, M.D., Acting Commissioner, United States Food and Drug Administration, Silver Spring, MD; O'Connell, Dawn, Assistant Secretary for Preparedness and Response, United States Department of Health and Human Services, Washington, DC.
Date/time/place of a event note	Date of hearing: 2021-07-20.
Source of description	Description based on online resource; title from PDF title page (GovInfo, viewed April 07, 2023).
Issued in other form	Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Path forward
Genre/form	Legislative hearings.
Standard identifier#	46-775 (GPO jacket number)
GPO item number	1043-C (online)
Govt. docs number	Y 4.L 11/4:S.HRG.117-195

Click here for more information about this title